NASDAQ: CTHRCharles & Colvard Ltd Stock
$0.94+0.01 (+1.08%)
Updated Jun 5, 2023
CTHR Price
$0.94
Fair Value Price
$1.30
Market Cap
$28.69M
52 Week Low
$0.75
52 Week High
$1.47
P/E
-2.76x
P/B
0.59x
P/S
0.84x
PEG
N/A
Dividend Yield
N/A
Revenue
$33.69M
Earnings
-$10.29M
Gross Margin
40.2%
Operating Margin
-13.05%
Profit Margin
-30.5%
Debt to Equity
0.15
Operating Cash Flow
-$4M
Beta
0.5
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CTHR Overview
Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. It also markets and distributes lab grown diamonds, and finished jewelry with lab grown diamonds under the Caydia brand. The company sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com, third-party online marketplaces, drop-ship, and other e-commerce outlets. Charles & Colvard, Ltd. was founded in 1995 and is headquartered in Morrisville, North Carolina.
Zen Score
–
Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CTHR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CTHR ($0.94) is undervalued by 27.65% relative to our estimate of its Fair Value price of $1.30 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CTHR ($0.94) is significantly undervalued by 27.65% relative to our estimate of its Fair Value price of $1.30 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
CTHR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CTHR due diligence checks available for Premium users.
Be the first to know about important CTHR news, forecast changes, insider trades & much more!
CTHR News
Valuation
CTHR fair value
Fair Value of CTHR stock based on Discounted Cash Flow (DCF)
Price
$0.94
Fair Value
$1.30
Undervalued by
27.65%
CTHR ($0.94) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CTHR ($0.94) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CTHR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CTHR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.76x
Industry
8.78x
Market
53.21x
CTHR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.59x
Industry
2.66x
CTHR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CTHR's financial health
Profit margin
Revenue
$6.6M
Net Income
-$8.4M
Profit Margin
-126.4%
CTHR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CTHR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$56.4M
Liabilities
$7.4M
Debt to equity
0.15
CTHR's short-term assets ($25.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CTHR's short-term assets ($25.68M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CTHR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CTHR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$773.2k
Investing
-$281.5k
Financing
$0.0
CTHR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CTHR vs Luxury Stocks
Charles & Colvard Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.